Statements (46)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Acquired by Illumina in 2021
|
| gptkbp:application |
cancer research
clinical research microbial genomics agricultural genomics human genomics |
| gptkbp:awards |
Various industry awards
|
| gptkbp:ceo |
gptkb:Christian_Henry
|
| gptkbp:collaborations |
Collaborations with academic institutions
Partnerships with pharmaceutical companies |
| gptkbp:community_engagement |
Educational initiatives in genomics
Support for open-source genomics tools |
| gptkbp:competitors |
gptkb:Oxford_Nanopore_Technologies
gptkb:Illumina |
| gptkbp:conference |
Participation in genomics conferences
|
| gptkbp:employees |
~500 (2021)
|
| gptkbp:focus |
long-read sequencing technology
|
| gptkbp:founded |
gptkb:2004
|
| gptkbp:founder |
gptkb:Hugh_Martin
|
| gptkbp:future_plans |
Development of new applications for sequencing
Expansion of sequencing technology |
| gptkbp:headquarters |
gptkb:Menlo_Park,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pac Bio
|
| gptkbp:impact |
Significant impact on genomics research
|
| gptkbp:industry |
gptkb:Company
|
| gptkbp:invention |
Numerous patents in sequencing technology
|
| gptkbp:market |
genomics
|
| gptkbp:partnership |
Collaboration with various research institutions
|
| gptkbp:products |
RSII System
Sequel System |
| gptkbp:publishes |
Numerous scientific publications
|
| gptkbp:receives_funding_from |
Venture capital funding
|
| gptkbp:research_focus |
epigenetics
transcriptomics metagenomics genomic variation structural variation |
| gptkbp:revenue |
$100 million (2020)
|
| gptkbp:specializes_in |
DNA sequencing
|
| gptkbp:stock_exchange |
gptkb:NASDAQ
|
| gptkbp:symbol |
gptkb:PACB
|
| gptkbp:technology |
gptkb:Single_Molecule,_Real-Time_(SMRT)_sequencing
|
| gptkbp:website |
www.pacb.com
|
| gptkbp:bfsParent |
gptkb:SMRT_cell_technology
|
| gptkbp:bfsLayer |
7
|